Quarterly report pursuant to Section 13 or 15(d)

NATURE OF OPERATIONS (Details)

v3.24.3
NATURE OF OPERATIONS (Details) - USD ($)
 1 Months Ended 9 Months Ended
Oct. 01, 2024
Nov. 15, 2023
May 16, 2023
Jul. 25, 2022
Jun. 29, 2021
Feb. 28, 2018
Sep. 30, 2024
Dec. 31, 2023
Warrant exercise price (in dollars per share)     $ 2.9999          
Shares issued (in shares)     601,851 1,159,211 2,875,000      
Gross proceeds from stock issue     $ 4,000,000.0 $ 4,200,000 $ 17,300,000      
Share price (in dollars per share)     $ 3.00   $ 6.00      
Pre-funded Warrant Exercise (in shares)     731,482 130,769        
Cash             $ 5,762,564 $ 7,474,188
Number of warrants     731,482          
Series A warrants                
Number of warrants       1,289,980        
Series B warrants                
Number of warrants       1,289,980        
Series C warrants                
Warrant exercise price (in dollars per share)     $ 3.26          
Number of warrants     1,333,333          
Series D warrants                
Warrant exercise price (in dollars per share)     $ 3.26          
Number of warrants     1,333,333          
At the Market Offering                
Shares issued (in shares) 25,000           1,994,069  
Gross proceeds from stock issue             $ 6,400,000  
Aggregate offering price   $ 17,000,000.0         $ 8,000,000.0  
At the Market Offering | Aggregate                
Shares issued (in shares)             2,692,190  
Gross proceeds from stock issue             $ 9,000,000.0  
ACX362E                
Cash paid           $ 110,174    
Future commitment           700,000    
Royalty payments           $ 50,000    
Royalty payments on net sales (as a percent)           4.00%    
ACX362E | Members' Equity, Class B                
Granting (in shares)           100,000    
Warrant exercise price (in dollars per share)           $ 0.10